why choose us

First received: January 22, 2025

Clinical Trial: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of RLYB116 in Healthy Participants

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Hematologic Diseases

Study Type: INTERVENTIONAL


Official Title: Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RLYB116 in Healthy Participants

Brief Summary: This study will investigate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of RLYB116 (with an improved impurity profile) following repeated administration of RLYB116 in healthy participants.

Read more